Tag: Larimar Therapeutics Inc.

Analysts Viewpoint

Larimar Therapeutics Inc’s recently made public that its Director Flynn James E acquired Company’s shares for reported $37.5 million on

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Larimar Therapeutics